Refine Results
  1. "Journal of Thoracic Oncology"
Formats
  1. Meeting Abstract (312)
  2. Journal Article (211)
Groups
  1. Thoracic Malignancies Disease Management Team (485)
  2. Thoracic Oncology Service (272)
  3. Solid Tumor Oncology Division (250)
  4. Surgery (212)
  5. Thoracic Oncology (197)
  6. Survivorship Research (75)

More Groups

People
  1. Valerie Rusch (123)
  2. William Travis (114)
  3. Mark Kris (95)
  4. Gregory Riely (82)
  5. Prasad Adusumilli (78)
  6. Lee Krug (50)

More People

Years
  1. 2019 (2)
  2. 2018 (82)
  3. 2017 (64)
  4. 2016 (23)
  5. 2015 (76)
  6. 2014 (31)

More Years

Publications
  1. Journal of Thoracic Oncology (523)
Publishers
  1. Elsevier Inc. (523)

Results (523)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: A propensity score–matched analysis
    Journal Article

    Eguchi, T.; Kameda, K.; Lu, S.; Bott, M. J.; Tan, K. S.; Montecalvo, J.; Chang, J. C.; Rekhtman, N.; Jones, D. R.; Travis, W. D.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Procedure-specific risk prediction for recurrence in patients undergoing lobectomy or sublobar resection for small (≤2 cm) lung adenocarcinoma: An international cohort analysis
    Journal Article

    Bains, S.; Eguchi, T.; Warth, A.; Yeh, Y. C.; Nitadori, J. I.; Woo, K. M.; Chou, T. Y.; Dienemann, H.; Muley, T.; Nakajima, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • First-line nivolumab + ipilimumab in Asian patients with advanced NSCLC and high TMB (≥ 10 mut/Mb): Results from CheckMate 227
    Meeting Abstract

    Park, K.; Lee, J.; Sakai, H.; Lee, K.; Ohe, Y.; Kim, S.; Fukuhara, T.; Kang, J.; Yu, C.; Daga, H.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Preliminary clinical activity of repotrectinib (TPX-0005) in advanced ROS1 fusion-positive non-small cell lung cancer
    Meeting Abstract

    Ou, S.; Cho, B. C.; Kim, D.; Drilon, A.; Lee, J.; Lin, J.; Zhu, V.; Ahn, M.; Camidge, D. R.; Shanna Stopatschinskaja, S.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Tepotinib in non-small cell lung cancer with MET exon 14-skipping mutations or MET amplification: A phase 2 trial in progress
    Meeting Abstract

    Paik, P.; Sakai, H.; Bruns, R.; Scheele, J.; Straub, J.; Felip, E.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • SLFN11 expression and efficacy of PARP inhibitor therapy in extensive stage small cell lung cancer: ECOG-ACRIN 2511 study
    Meeting Abstract

    Owonikoko, T.; Dahlberg, S.; Sica, G.; Poirier, J.; Byers, L.; Rudin, C.; Wistuba, I.; Ramalingam, S.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Targeting NFE2L2 mutations in advanced squamous cell lung cancers with the TORC1/2 inhibitor TAK-228
    Meeting Abstract

    Paik, P.; Ahn, L.; Ginsberg, M.; McFarland, D.; Doyle, L.; Rudin, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study of the AXL inhibitor DS-1205c in combination with osimertinib in subjects with metastatic or unresectable EGFR-mutant NSCLC
    Meeting Abstract

    Jänne, P.; Yu, H.; Shipitofsky, N.; Vigliotti, M.; Goldberg, T.; Li, J.; Mcgill, J.; Zhang, H.; Yu, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study of the anti-HER3 antibody drug conjugate U3-1402 in metastatic or unresectable EGFR-mutant NSCLC
    Meeting Abstract

    Jänne, P.; Yu, H.; Johnson, M.; Steuer, C.; Vigliotti, M.; Shipitofsky, N.; Guevara, F. M.; Chen, S.; Yu, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Improving cardiac tamponade outcomes through less invasive interventions and earlier recognition
    Meeting Abstract

    Murphy, K.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save